Literature DB >> 24108066

Treatment of intractable anorexia nervosa with inactivation of the nucleus accumbens using stereotactic surgery.

Jing Wang1, Chongwang Chang, Ning Geng, Xuelian Wang, Guodong Gao.   

Abstract

BACKGROUND: For 30% of anorexia nervosa (AN) patients, conventional treatments are unsuccessful; this is termed intractable AN.
OBJECTIVES: This study investigates whether ablation of the nucleus accumbens (NAc) using stereotactic surgery can arouse the physiological drive to eat in intractable AN patients.
METHODS: Eight patients with intractable AN were included: 6 patients underwent bilateral stereotactic radio frequency ablation in the NAc and 2 patients received bilateral NAc deep brain stimulation (DBS). Observations were made for basic vital signs, body mass index (BMI), menstruation, depression, anxiety, obsessive-compulsive disorder, personality, intelligence, memory, quality of life, social functioning, as well as complications and adverse events associated with the treatment.
RESULTS: Basic vital signs, BMI and menstruation had recovered 1 year after the operation. Depression, anxiety and obsessive-compulsive disorder were improved 1 year postoperatively. There were changes in personality scores for psychoticism, neuroticism and lie tendencies that seemed to be helpful to the recovery from AN. Intelligence and memory improved after 6 months postoperatively. Quality of life and social functioning were dramatically improved at 1 year postoperatively.
CONCLUSIONS: The results of this study reveal that ablation of the NAc can increase the AN patients' physiological drive to eat. Furthermore, there were no severe and/or life-influencing complications associated with the treatment.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24108066     DOI: 10.1159/000348278

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  8 in total

Review 1.  Neuromodulation for the treatment of eating disorders and obesity.

Authors:  Darrin J Lee; Gavin J B Elias; Andres M Lozano
Journal:  Ther Adv Psychopharmacol       Date:  2017-12-08

2.  Neurosurgery and neuromodulation for anorexia nervosa in the 21st century: a systematic review of treatment outcomes.

Authors:  Stuart B Murray; Michael Strober; Reza Tadayonnejad; Ausaf A Bari; Jamie D Feusner
Journal:  Eat Disord       Date:  2020-09-29       Impact factor: 3.222

Review 3.  Deep Brain Stimulation-Possible Treatment Strategy for Pathologically Altered Body Weight?

Authors:  Philip Prinz; Andreas Stengel
Journal:  Brain Sci       Date:  2018-01-22

4.  Deep brain stimulation in the bed nucleus of the stria terminalis and medial forebrain bundle in a patient with major depressive disorder and anorexia nervosa.

Authors:  Patric Blomstedt; Matilda Naesström; Owe Bodlund
Journal:  Clin Case Rep       Date:  2017-03-31

5.  Deep Brain Stimulation in Anorexia Nervosa: Hope for the Hopeless or Exploitation of the Vulnerable? The Oxford Neuroethics Gold Standard Framework.

Authors:  Rebecca J Park; Ilina Singh; Alexandra C Pike; Jacinta O A Tan
Journal:  Front Psychiatry       Date:  2017-03-20       Impact factor: 4.157

Review 6.  Neurostimulation in Clinical and Sub-clinical Eating Disorders: A Systematic Update of the Literature.

Authors:  Bethan Dalton; Savani Bartholdy; Iain C Campbell; Ulrike Schmidt
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 7.  Brain Stimulation in Eating Disorders: State of the Art and Future Perspectives.

Authors:  Philibert Duriez; Rami Bou Khalil; Yara Chamoun; Redwan Maatoug; Robertas Strumila; Maude Seneque; Philip Gorwood; Philippe Courtet; Sébastien Guillaume
Journal:  J Clin Med       Date:  2020-07-23       Impact factor: 4.241

8.  Mood Regulatory Actions of Active and Sham Nucleus Accumbens Deep Brain Stimulation in Antidepressant Resistant Rats.

Authors:  Rajas P Kale; Thanh Thanh L Nguyen; J Blair Price; Nathanael J Yates; Ken Walder; Michael Berk; Roy V Sillitoe; Abbas Z Kouzani; Susannah J Tye
Journal:  Front Hum Neurosci       Date:  2021-07-19       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.